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Abstract
Fixation with formalin, a widely adopted procedure to preserve tissue samples, leads to extensive degradation of nucleic
acids and thereby compromises procedures like microarray-based gene expression profiling. We hypothesized that RNA
fragmentation is caused by activation of RNAses during the interval between formalin penetration and tissue fixation. To
prevent RNAse activation, a series of tissue samples were kept under-vacuum at 4uC until fixation and then fixed at 4uC, for
24 hours, in formalin followed by 4 hours in ethanol 95%. This cold-fixation (CF) procedure preserved DNA and RNA, so that
RNA segments up to 660 bp were efficiently amplified. Histological and immunohistochemical features were fully
comparable with those of standard fixation. Microarray-based gene expression profiles were comparable with those
obtained on matched frozen samples for probes hybridizing within 700 bases from the reverse transcription start site. In
conclusion, CF preserves tissues and nucleic acids, enabling reliable gene expression profiling of fixed tissues.
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Introduction
Since its introduction as a histological fixative back in the 19th
century [1], the 4% formaldehyde solution in water (formalin) has
been adopted as the fixative of choice in histopathology. However,
the uses of formalin-fixed tissues have varied over time. Originally,
optimal morphological preservation was the sole requirement, but in
more recent times, with the advent of immuno-histochemical typing,
reliable antigenic preservation is also required [2,3]. As a
consequence, the protocols of formalin fixation have become stricter.
This issue is particularly relevant in onco-pathology for the evaluation
of factors predicting responsiveness to therapeutic treatments, and
thus, fixation in phosphate buffered formalin (PBF) of breast cancer
tissue blocks for no less than 6 and no more than 48 hours is now
required in order to guarantee an optimal evaluation of Estrogen
(ER) and Progesterone Receptors (PgR) and HER2 expression [4,5].
In more recent times, a crucial request in cancer pathology has
been nucleic acid preservation from formalin-fixed paraffin-
embedded (FFPE) tissues because large tissue archives would thus
be available for gene expression profiling, with the goal of
generating new and reliable diagnostic and prognostic parameters
[6,7]. The first and most crucial issue that must be addressed for
molecular gene signatures is ensuring that the sample is properly
collected to obtain good quality RNA. The accuracy of molecular
tests is utterly dependent on careful preservation of biological
samples prior to analysis and then on an adequate sampling of
fresh tissues that have to be representative of and enriched for the
tumor cell population in order to obtain the specific RNA target.
Studies conducted on the preservation status of nucleic acids in
FFPE tissues generally agree on the relatively good (though not
optimal) preservation of DNA [8]. On the contrary, RNA has
been found to be heavily degraded and fragmented so that only
short sequences (approximately 100–200 nucleotides) can be
recognized and amplified [9–13]. The reasons for this effect are
presently unknown, but some hints can be derived from the
numerous studies conducted on the reaction of formaldehyde with
different tissue components and specifically with nucleic acids [14–
16].The main effect of formaldehyde in tissues is linked to the
formation of methylol groups on amino groups first, followed by
the establishment of cross-linking methylene groups that lead to
proper fixation [13]. Bases of nucleic acids are involved in this
process, resulting in cross-linking with side-chain amino groups of
proteins. However, this linkage is at least partly reversible
following extensive treatment of FFPE tissue sections with
peptidases and high temperature [9,13,17,18]. We conclude that
cross-linking of nucleic acid bases cannot be the sole responsible
for nucleic acid fragmentation and degradation. Chung YJ et al.
[9] have demonstrated that substantial RNA degradation may
occur during the so called ‘‘warm ischemia’’ that refers to the time
of transfer from an operation room (or removal of blood supply) to
pathology laboratory. The RNA degradation due to warm
ischemia may be slowed down by cooling the specimen. The
ischemic process may continue during fixation [9]. In fact, while
formalin penetration is a rather fast process, tissue fixation is
known to be a slow process that requires long time exposure
[16,18]. Another suggested mechanism of RNA degradation in
FFPE tissues is incomplete dehydration from inadequate tissue
processing [9].
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Based on these hypotheses, we have further considered that
RNA degradation would be inhibited by maintaining low
temperature through all the process of fixation. The aim of the
present study was thus to evaluate whether a protocol based on
processing tissues with formalin at low temperature would better
preserve nucleic acid integrity, while preserving morphological
and antigenic features as well. The presently described cold
fixation (CF) process in formalin was experienced on several
human specimens, specifically in colon and breast cancers.
Results
Morphology and antigen preservation
No distinction was observed in morphology between tissues
processed either using standard formalin fixation at room
temperature or CF (4uC) method, with blinded pathologists opting
in 7 out of 10 cases for the latter as better preserved. No shrinking
or distortion artifacts were observed (see Figure S1). No
appreciable difference was observed in immunohistochemical
reactivity for the markers (ER, PgR, Ki67, HER2, CEA, CK20)
tested.
RNA preservation
The RNA quality as initially assessed by lab-on-chip analysis
showed that in the control fresh-frozen specimens, the RIN (RNA
Integrity Number) value ranged between 8.5 and 7.2. Values were
much lower (RIN ranging between 3.80 and 2.20) in RNA samples
obtained from paraffin sections of CF-treated tissues. As expected,
after standard formalin fixation the RIN values were not
measurable.
The RT-PCR study for homeobox genes expression was
conducted in parallel on fresh frozen, CF-treated and standard
FFPE samples of 10 cases with amplification of the HMBS/ABL1/
B2M genes (128 bp, 193 bp and 334 bp in length, respectively)
and of G6PD (660 bp). The CF processing allowed the
amplification of all genes up to 660 bp, whereas RNA extracted
from standard-fixed specimens allowed the amplification of the
shorter segments (128 bp and 193 bp) only (Figure 1).
We used the amplification of segments of CK20 RNA of
different length (329 bp, 500 bp and 716 bp) as a tissue-specific
marker of colon cancer specimens. The amplification of all the
CK20 RNA segments (up to 716 bp) was obviously successful with
RNA extracted from all of the frozen samples, while RNA
segments were successfully amplified only in 3 of the standard-
fixed tissues and the fragments were no more than 329 bp in
length. In all the CF-treated specimens, RNA amplification was
consistently successful at 329 and 500 bp, and also occasionally at
higher lengths (716 bp).
The expression of the mammaglobin gene (331 bp) was tested in
the four samples of breast cancer tissue and the ER gene (349 bp)
in the three cases showing ER protein expression by immunohis-
tochemistry. The RT-PCR tests were consistently positive in
frozen and CF-treated samples, whereas in standard-fixed tissues,
mammaglobin, but not ER was positive in 2 out of four cases.
Microarray analysis
The standard protocol for Illumina Beadarray gene expression
analysis was employed on RNAs obtained from frozen, CF and
standard-fixed samples. This protocol employs a T7-oligo-dT
primer for cDNA synthesis, so that reverse transcription (RT)
starts from the beginning of the poly(A) tails. Therefore, if the
RNA is fragmented, an array probe gives reliable signal only if the
distance of its target sequence from the poly(A) site is shorter than
the average length of the RNA fragments. To annotate the probes
of the Human HT-12v4 BeadArray with their distance from the
poly(A) site, we blasted all of them against the human RefSeq
database, containing well-annotated mRNA transcripts. In total,
18470 probes were found to univocally match one RefSeq
transcript, and were subdivided into 13 bins based on the distance
of their target sequence from the transcript poly(A) site (from 50–
100 bases to more than 2000 bases). For each bin, the fraction of
probes giving reliable expression signal (detection p-value,0.005)
was calculated. This analysis is summarized in Figure 2. While
RNAs from standard-fixed samples yielded, as expected, a
sufficient fraction of detection only for probes binding up to
200b from the poly(A), RNAs from cold-fixed samples gave a
significantly better profile, with a good fraction of detection for
probes binding also 500–700b from the poly(A). Figure S2 shows
tissue-specific analysis of cancer samples from colon (four), breast
(four), pancreas (one) and stomach (one). For all colorectal cancer
samples, a replicate cold fixation was performed and RNA was
extracted. Overall, fragment length of RNA from cold-fixed
samples was comparable for all tissues, and reproducible within
tissue and within sample, with slightly shorter fragments only for
pancreatic cancer.
We then tested the correlation between gene expression profiles
obtained from frozen and fixed samples of the same tissue
specimen. Using all probes, the average Pearson correlation
between frozen and standard fixed or cold-fixed samples was
respectively 0.61560.087 and 0.89460.044. Interestingly, the
average Pearson correlation between two cold-fixed samples from
the same tissue was extremely high (0.98460.02). Individual
pairwise correlations and representative dot plots are provided in
Figure S3. The same correlation analysis was then run using
probes binned for their distance from the poly(A) site. Standard
fixed samples displayed acceptable correlations with their frozen
counterparts only for probes binding up to 200 bases from the RT
start site (Figure 3 A), while for further upstream probes the
correlation dropped to unacceptable levels (Figure 3 B–D).
Conversely, CF samples displayed highly correlated gene expres-
sion profiles for probes binding up to 700 bases from the poly(A)
(Figure 3 E–G), with reasonable correlation still present for probes
more than 700 bases-away from the RT start site (Figure 3 H).
Detailed binned correlation analysis for all sample pairs is
Figure 1. RT-PCR for G6PD on cold-fixed (CF 1–10) and routine FFPE (R 1–6) samples. A specific signal for G6PD was detected at 660 bp in
CF-treated tissues.
doi:10.1371/journal.pone.0021043.g001
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provided in Figure S4. Finally, we verified if technical artifacts
deriving from the CF procedure could impair comparability
between gene expression profiles of CF and frozen samples from
the same specimen. To this aim, we performed data clustering
using 12526 probes mapped within 700 bases from the poly(A) site.
For each probe, the signal was averaged across all samples, and the
Log(2) ratio was calculated against this average for each frozen and
CF sample. Hierarchical clustering with cosine correlation was
performed with the GEDAS software [19] and showed a tight co-
clustering of frozen and CF samples from the same specimen
(Figure 4). Overall, gene expression profiling analysis showed that
RNAs from CF samples are significantly less fragmented that those
from standard FFPE samples, with high amounts of more than
500-base long fragments.
DNA preservation
DNA study by FISH performed on the breast cancer specimens
using HER2 gene as a marker showed identical result in the CF-
processed and matched standard-fixed samples.
Using QIAamp DNA minikit and PCR analyses, CK20 DNA
fragments at 755 bp length were assessable in the four colon
cancer cases in parallel in fresh-frozen, standard-fixed and CF
fixed specimens.
Discussion
Following the demonstration that low temperature better
preserves RNA, we have designed a protocol that considers
keeping the specimen at 4uC from the surgical excision up to
formalin fixation and the first step of alcohol dehydration.
According to Fox and colleagues [15], there is a paradox in the
working mechanism of formaldehyde because it penetrates tissues
rapidly, but it fixes them very slowly. During this lapse of time,
RNA degradation may occur as a consequence of warm ischemia
[9]. In the present experiments, we extended the immersion time
up to 24 hours at 4uC, thus limiting RNAse activity and allowing
complete penetration by formalin and proper fixation of the tissue.
At the end of this ‘‘cold penetration’’ period, methylene glycol,
the hydrated form acquired by formaldehyde in aqueous solutions,
has already been establishing reactive groups, mainly with
hydroxyl-methyl side groups of proteins, but the extensive
formation of methylene cross-links, leading to proper tissue
fixation, is a progressive and lengthy process [16]. Standard
formalin fixation in about 24 hours, as currently practiced in
routine histopathology, is therefore the result of a compromise
between the request of a rapid diagnosis and a satisfactory
morphological preservation. In the present study, CF-treated
tissues were morphologically similar to standard-processed tissues:
no stretching or cohartation artifacts were noticed (see Figure S1).
The immunohistochemical reaction for the markers, which are
routinely investigated in colorectal (CEA, CK20) and breast
cancers (ER, PgR, Ki67 and HER2) gave results indistinguishable
from those obtained from the samples of the same cases processed
by standard method. However, the main objective of the present
study was to preserve nucleic acid integrity. The preservation of
DNA in FFPE tissues is known to be relatively good [6,7] and it
was not modified by CF. Major problems are instead related to
successful extraction of usable RNA from FFPE samples.
Farragher and colleagues [20] suggested that the limiting factors
for RNA extraction from FFPE samples are: cross-linkage between
nucleic acids and proteins, addition of monomethylol groups to the
bases that modify the poly A tail inhibiting oligo primer annealing
to the polyA tail and consequently the reverse transcription
reaction and finally, the natural RNA degradation in the tissue
prior to fixation due to RNAses activity. RNases are ubiquitous in
the environment, and they are present in relatively high
concentrations in many biological materials. Thus, the same
authors suggest a change in clinical practice for the development
Figure 2. Messenger RNAs from cold-fixed samples are detected by microarray probes hybridizing more than 500b. Messenger RNAs
from cold-fixed samples are detected by microarray probes hybridizing more than 500b upstream from the reverse transcription start site. Graph
showing the fraction of probes with detectable signal (y-axis) for each bin of distance of target sequence from the mRNA poly(A) site from which RT is
initiated (x-axis).
doi:10.1371/journal.pone.0021043.g002
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of a standardised, consistent and short time interval between
removal of specimen and fixation. In our experience, the poor
preservation and fragmentation of nucleic acids currently observed
in formalin-fixed tissues [6,7,10–13] can, at least partly, be
prevented by keeping low temperatures before and during fixation.
Our procedure includes in fact, the use of a vacuum to seal the
tissue and facilitate the transfer at 4uC, which already prevents
RNA degradation as previously demonstrated by our group [21].
Surprisingly, no studies are reported in the literature on the
temperature of formalin as a variable and on the use of cold
formalin fixation in order to preserve RNA in FFPE tissues. RIN
analysis showed that significant RNA fragmentation still occurred
in CF-processed tissues, but at a much lower extent than in
standard-processed tissues with good results even in tissues
obtained from pancreas and stomach that contain high level of
hydrolytic enzymes. For example, the pancreas is rich in RNase
(.1 mg RNase/1 g tissue) and is the source for most commercially
produced RNase A (and its glycosylated derivative, RNase B).
Recently, a gene expression assay (Whole-Genome DASL),
capable of generating whole-genome gene expression profiles
from degraded samples has been developed [22,23], with
amplicon sizes of 70–85 bp. At difference from these studies, the
present work aims at improving RNA integrity of FFPE specimens,
without changes of reagents or overall time of fixation. Indeed,
RT-PCR amplification [10] of RNA fragments up to 660 bp from
CF samples can be considered a notable improvement over room
temperature formalin fixation. Gene expression analysis using a
standard whole-genome microarray showed that mRNA profiles
of CF-treated samples are comparable to those of fresh-frozen
samples, which are, at present, the sole specimens considered
suitable for microarray-based gene expression profiling. While
RNAs from standard-fixed samples yielded, as expected, a
sufficient fraction of detection only for probes binding up to
200b from the poly(A), RNAs from cold-fixed samples gave a
significantly better profile, with good performances for probes
binding also 500–700b upstream from the poly(A). It should be
noted that in the case of the Illumina arrays used in this work,
12526 probes bind within 700 bases from the poly(A) site, which
renders analysis of CF samples already genome-wide and reliable
without need of dedicated probes or protocols.
Finally, the issue of adequacy of the material subjected to
molecular analyses is of paramount importance. In routine practice,
a significant proportion of molecular tests performed on fresh tissue
samples are not successful due to incorrect sampling of the target
area (for example no cancer cells in the sample). The present CF
protocol overcomes these problems meeting the requirement of a
correct identification of the material to be examined.
In conclusion, the presently proposed procedure of tissue
conservation results in a definitely lower degree of mRNA
fragmentation, while keeping the basic advantages that make
formalin the fixative of choice in diagnostic histopathology.
Although not yet reaching the nucleic acid quality obtained from
fresh-frozen material, the CF approach represents a definite
improvement in the degree of preservation of the molecular
structures of FFPE tissues. Most importantly, this approach does
not require profound changes in routine procedures currently
adopted by most pathology laboratories, which renders its
implementation feasible for standard practice. The possibility of
obtaining high-quality mRNA from archival tissues opens
prospects for wider gene expression profiling than presently
feasible [24,25].
Materials and Methods
Sample Collection Procedures
Following a procedure first published by our group [21] and
now used as a standard in our hospital [26], four consecutive colon
cancer, four breast carcinoma specimens, one case of pancreatic
cancer and one case of gastric cancer were under-vacuum sealed
in plastic bags using a semi-professional machine (Mod. VAC 10,
by Milestone, Bergamo, Italy; see http://www.milestonemedsrl.
com) inside the surgical theatre immediately after surgery, and
kept at 4uC until transfer to the pathology laboratory. Once in the
pathology lab the surgical specimens were processed without
delay.
From each specimen, three samples were taken and processed
as follows:
a) Standard fixation procedure (FFPE): the sample (4 mm. thick) was
fixed for 24 hours in 4% neutral-buffered formalin (NBF)
(Histo-Line Laboratories, Milan, Italy) at room temperature
(RT), routinely processed to paraffin embedding with an
automatic processor (Leica ASP 300, Leica Microsystems,
Wetzlar, Germany) and embedded in paraffin wax.
Figure 4. Frozen and cold-fixed samples from the same
specimen cluster together. Hierarchical clustering of samples based
on 12526 microarray probes hybridizing up to 700 bases from the
poly(A) site. CRC, Colorectal cancer; PCa, Pancreatic cancer; GCa, Gastric
cancer; BrCa, Breast cancer.
doi:10.1371/journal.pone.0021043.g004
Figure 3. Frozen and cold-fixed samples generate highly correlated expression profiles. Dot plots comparing signal intensities of frozen
vs standard-fixed tissues (A–D) or frozen vs cold-fixed tissues (E–H). The plots show four groups of probes based on the distance of their target
sequence from the RT start site: less than 200 bases (A,E) 200–500 bases (B, F) 500–700 bases (C, G), more than 700 bases (D, H).
doi:10.1371/journal.pone.0021043.g003
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b) Cold fixation procedure (CF): the sample was immersed in pre-
cooled 4% NBF (Histo-Line Laboratories, Milan, Italy) at
4uC for 24 hours. Thereafter, the specimens were transferred
in ethanol 95% at 4uC for 4 hours in order to keep nucleases
inhibited during the time of ethanol penetration. The tissues
were processed to paraffin embedding in the same processor
(Leica ASP 300, Leica Microsystems, Wetzlar, Germany) and
following the same program used for FFPE, but skipping the
formalin and the first ethanol 95% steps.
c) Freezing procedure: the sample was frozen in liquid nitrogen
immediately after dissection and stored at 280uC.
The study was restricted to surgical specimens and to tumor
larger than 2 cm. The patients were informed of the study
protocol. Verbal consent for anonymous use of the tissue for study
purposes was then obtained. In order to assure the diagnoses and
tumor staging the frozen samples, cold and standard fixed samples
were examined on hematoxylin and eosin (H&E) stained slides
before proceeding to the experimental part. The design of the
study (Figure 5) was approved by the ethic institutional review
board for ‘‘Bio-banking and use of human tissue for experimental
studies’’ of the Department of Biomedical Sciences and Human
Oncology of the University of Torino. The same ethic institutional
review board approved that written consent from the patients was
not needed, given that the study did not interfere with diagnosis or
treatment decisions. Data were analyzed anonymously.
Staining, immunohistochemistry and Fluorescent In Situ
hybridization (FISH) procedures
Sections 3 mm in thickness were cut from FFPE and CF blocks
and routinely stained with hematoxylin and eosin (H&E).
Immunohistochemistry was performed on tissue sections using
an automated slide processing platform (Ventana BenchMark
AutoStainer, Ventana Medical Systems, Tucson, AZ, USA) and
the following primary antibodies: CK20 monoclonal mouse
antibody (clone Ks 20.8, diluted 1:100, DAKO, Glostrup,
Denmark) and CEA monoclonal antibody (clone II-7 diluted
1:100, DAKO, Glostrup, Denmark) to stain colon carcinomas;
prediluted anti-ER rabbit monoclonal antibody (clone SP1,
Ventana-Diapath, Tucson, AZ, USA), prediluted anti-PgR rabbit
monoclonal antibody (clone 1E2, Ventana-Diapath), anti-Ki67
monoclonal antibody (clone MIB1, diluted 1:100 Dako, Glostrup,
Denmark) and anti-HER2 monoclonal antibody (clone 4B5,
Ventana-Diapath, Tucson, AZ, USA) for breast cancer specimens.
Positive and negative controls (omission of the primary antibody
and IgG-matched serum) were included for each immunohisto-
chemical run. FISH assay to evaluate HER2 gene amplification
was performed, following a previously reported protocol [27].
RNA extraction
RNA was extracted from FFPE, CF and fresh frozen blocks.
The number of sections needed to obtain a nucleic acid yield
adequate for molecular analysis depended on the type of tissue
samples (fibrosis, cellularity) and on the sample dimensions. On
equal sample characteristics the number of sections was higher for
paraffin embedded tissue because of the expected decrement in
RNA and DNA yield from fresh to formalin fixed tissues. Sections
were collected in a 1.5 ml sterile Eppendorf tube.
RNA isolation from the FFPE and CF samples was performed
using the MasterPure Purification kit (Epicentre, Madison, WI,
USA). Sections were deparaffinized by incubations in xylene
followed by incubations in 100% ethanol. The ethanol was
discarded, and the pellet was air-dried for several minutes at room
temperature before Proteinase K treatment, according to the
Chen optimized extraction ‘‘Method 3’’ for FFPE tissues [28].
RNA extraction from fresh frozen sections was performed with
1 ml of TrizolH reagent (Invitrogen, Carlsbad, CA, USA)
according to manufacturer’s instructions.
RNA pellets were resuspended in DEPC-treated water, and
RNA concentrations were measured with a spectrophotometer
(BioPhotomer Eppendorf AG, Hamburg, Germany). RNA
samples were stored at 280uC until further analysis. The quality
and quantity of the extracted RNA was also assessed using a
Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA) based on
a 28S/18S ribosomal RNA ratio and on the RIN.
DNA extraction
DNA was isolated from FFPE, CF and fresh frozen blocks. The
number of sections obtained for DNA analysis followed the same
criteria reported for RNA extraction. Sections were collected in a
1.5 ml sterile Eppendorf tube and treated according to the
manufacturer’s protocol for the QIAamp DNA minikit (QIAGEN
Ltd, Crawley, UK). The DNA concentration was measured
spectrophotometrically, and the eluted DNA was stored at 4uC
until further analysis.
Reverse Transcriptase–Polymerase Chain Reaction (RT-
PCR) and PCR Analysis
RT-PCR was performed after a DNAse treatment step with the
TURBO DNA-freeTM Kit (Ambion, Foster City, CA, USA). For
Figure 5. Study flowchart. Flowchart illustrating the design of the
study.
doi:10.1371/journal.pone.0021043.g005
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each sample, up to 4 mg of RNA was reverse transcribed to cDNA
with a High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA, USA). RNA samples without Reverse
Transcriptase were reverse transcribed as negative controls for
DNA contamination in the PCR analyses.
Several tests were performed to evaluate the integrity of gene
sequences of different length (see list and sequences in Table S1).
Initially we investigated sequences of hydroxymethylbilane synthase
(HMBS, NM_001024382.1, NM_000190.3), abelson kinase (ABL1,
NM_005157.3, NM_007313.2) and beta2-microglobulin (B2M;
NM_004048.2) genes, Cytokeratin 20 (CK-20; KRT20, NM_01-
9010.1) (colon tissues), mammaglobin (SCGB2A2, NM_002411.2;
331 bp) and ER alpha (ESR1, NM_000125.3, NM_001122740.1,
NM_001122741.1, NM_001122742.1; 346 bp) (breast samples) but
finally, we performed a PCR for Homo sapiens glucose-6-phosphate
dehydrogenase (G6PD, NM_000402.3, NM_001042351.1), result-
ing in a target sequence of 660 bp (primers sequences: FW 59-
ATCTTGGTGTACACGGCCTC-39, REV 59- CAACCA-
CATCTCCTCCCTGT-39).
CK-20 (KRT20, NT_010783.15) PCR amplification was also
evaluated in genomic DNA samples (339 bp, 420 bp, 755 bp).
The PCR conditions are reported in Table S1. Reactions were
performed on PTC-100 Peltier Thermal Cycler (MJ Research,
Inc., MA, USA), and the PCR products were separated by
electrophoresis on ethidium bromide-stained 2% agarose gels. To
reduce the risk of contamination from previously amplified
products, separate areas were used for RNA isolation, amplifica-
tion and electrophoresis.
Microarray analysis
Biotinylated cRNA was prepared using the Illumina TotalPrep
RNA Amplification Kit (Ambion, Inc., Austin, TX) according to
the manufacturer’s recommendations starting with 500 ng of
total RNA. Hybridization of the cRNA to the HumanHT-12_V4
Expression BeadChip (Illumina, Inc., San Diego, CA), washing
and scanning were performed according to the Illumina
BeadStation 5006 manual (revision C). Microarray data were
summarized with the Beadstudio software (Illumina), and
subsequently analyzed using Excel (Microsoft). The whole
microarray dataset is MIAME compliant. Raw data are deposited
in Gene Expression Omnibus (GEO Accession number
GSE27175).
Supporting Information
Figure S1 Histology (H&E staining) of tissues processed
either routinely (FFPE) or following the CF procedure.
For all samples: (a) Cold-Fixed (106); (b) Cold-Fixed (206); (c)
Standard-Fixed (106); (d) Standard-Fixed (206).
(PDF)
Figure S2 Probe detection analysis on cancer samples
subdivided by tissue of origin. (a) Four CRCs; (b) Four
breast cancers; (c) One pancreatic and one stomach cancer. For all
CRC samples, a replicate cold fixation was performed and RNA
was extracted, to assess consistency of the procedure on the same
tissue sample.
(PDF)
Figure S3 Cold-fixed samples generate reproducible
expression profiles, highly correlated with those gener-
ated by frozen samples. (a) Pearson correlation between
frozen (F) and Cold-Fixed (CF) or Standard-Fixed (SF) samples,
plus correlation between replicate samples from the same cold-
fixed tissue. (b–e) Dot plots comparing, expression profiles of RNA
from, respectively: frozen vs standard-fixed tissue (b), Frozen vs
Cold-Fixed tissue of a representative CRC sample (c), frozen vs
Cold-Fixed tissue of a representative breast cancer sample (d),
Cold-fixed vs replicate sample extracted from the same cold-fixed
tissue (e).
(PDF)
Figure S4 RNA from cold-fixed samples generates
reliable expression profiles also with probes far away
from the Reverse Transcription start site. Pearson
correlation was analyzed for subgroups of microarray probes,
based on their distance from the transcript 39-end. (a) Breast
Cancer samples; (b) CRC samples; (c) Pancreas and stomach
cancer; (d) CRC replicated cold-fixed samples.
(PDF)
Table S1 RT-PCR conditions.
(PDF)
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